The Opportunity for OM Investors
LOS ANGELES, Oct. 18, 2024 /PRNewswire/ — The Law Offices of Frank R. Cruz announces that investors with substantial losses have an opportunity to take the lead in the securities fraud class action lawsuit against Outset Medical, Inc. (“Outset Medical” or the “Company”) OM.
Class Period: August 1, 2022 – August 7, 2024
Lead Plaintiff Deadline: October 28, 2024
The complaint alleges that, during the Class Period, Defendants withheld information from investors, including misleading points about Tablo products not being FDA-approved for continuous renal replacement therapy, the likelihood of an additional 510(k) application, and substantial risks leading to a potential halt in Tablo product sales. These failures, coupled with a deficient sales team and process, put the Company’s revenue growth at risk. Consequently, Defendants’ positive statements about the Company’s businesses were misleading.
If you’ve suffered a loss as a shareholder, opportunities await. Follow us on Twitter for updates or visit our website for more information.
To join the class action, no immediate action is required. You can choose legal counsel at your discretion or remain an absent member. For inquiries and further information, reach out to Frank R. Cruz at The Law Offices of Frank R. Cruz in Century City, California.
Remember, this publication may be perceived as Attorney Advertising in certain jurisdictions. Stay informed and connected in this pursuit of justice.
